An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

NCT00982735 · clinicaltrials.gov ↗
COMPLETED
Status
987
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Boehringer Ingelheim